Add‐on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream study-Reference-Cited by-同舟云学术

Add‐on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream study

Published:2020-12-10 Issue:2 Volume:23 Page:599-608
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Biester Torben¹^ORCID,Muller Ido²,von dem Berge Thekla¹^ORCID,Atlas Eran²,Nimri Revital³^ORCID,Phillip Moshe³⁴^ORCID,Battelino Tadej⁵⁶^ORCID,Bratina Natasa⁵⁶^ORCID,Dovc Klemen⁵⁶^ORCID,Scheerer Markus F.⁷,Kordonouri Olga¹^ORCID,Danne Thomas¹^ORCID

Affiliation:

1. Diabetes Centre for Children and Adolescents, Kinder und Jugendkrankenhaus, Auf der Bult Hannover Germany

2. DreaMed Diabetes Ltd Petah Tikva Israel

3. The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Centre for Childhood Diabetes, Schneider Children's Medical Centre of Israel Petah Tikva Israel

4. Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

5. Department of Paediatric Endocrinology, Diabetes and Metabolic Diseases UMC ‐ University Children's Hospital Ljubljana Slovenia

6. Faculty of Medicine University of Ljubljana Ljubljana Slovenia

7. AstraZeneca Wedel Germany

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14258

Reference30 articles.

1. https://www.nice.org.uk/guidance/ta597/resources/dapagliflozin-with-insulin-for-treating-type-1-diabetes-pdf-82607268776389. Accessed 01 Oct 2020.